Searched for
PSORIASIS
Sun Pharma shares jump over 9% after firm announces $12 billion Organon acquisitionSun Pharmaceutical Industries' shares surged after announcing the $11.75 billion acquisition of US-based Organon & Co., a global leader in ...27 Apr, 2026, 10.33 AM IST- ET Exclusive | Sun Pharma set to acquire Organon for $12.5 bn, its biggest till dateUS company’s board meeting is happening this weekend to finalise decision; an announcement is imminent later tonight or by Monday. Mumbai H...27 Apr, 2026, 08.52 AM IST
- Alembic Pharma gets USFDA nod for generic cancer, arthritis injectionAlembic Pharmaceuticals has received final approval from the US Food and Drug Administration for its generic methotrexate injection, used t...16 Apr, 2026, 01.06 PM IST
- No facials, no expensive beauty ingredients: Actress Priyanka Chopra Jonas reveals her beauty secret of her grandmother who passed away 94 with 'barely any wrinkles’Priyanka Chopra revealed her grandmother's secret to youthful skin: coconut oil. This natural ingredient combats microbes and reduces infla...15 Apr, 2026, 12.43 PM IST
- Sun Pharma shares tumble 4% as firm closes in on $12-billion Organon acquisition. What’s spooking investors?Shares of Sun Pharmaceutical Industries fell sharply after ET reported the company had submitted a $12-billion binding offer for Organon & ...10 Apr, 2026, 11.30 AM IST
- Sun Pharma’s Ilumya expansion bid gets USFDA nod for reviewSun Pharmaceutical has received a significant approval from the USFDA. The company's innovative drug, Ilumya, is now being considered for t...16 Mar, 2026, 09.01 PM IST
- 31-year-old suffered from rare immune condition, could barely do his job, shares the one habit which helped him healA 31-year-old man's psoriasis severely worsened after COVID-19, leading to significant weight loss and emotional distress. He found relief ...22 Dec, 2025, 07.36 PM IST
- Sun Pharma launches Ilumya for psoriasis treatment in IndiaSun Pharmaceutical Industries has launched its innovative drug Ilumya in India. This medication treats moderate-to-severe plaque psoriasis....01 Dec, 2025, 07.23 PM IST
- Sun Pharma brings global psoriasis drug ILUMYA to Indian marketSun Pharmaceutical Industries has launched its innovative biologic drug, ILUMYA, in India for moderate-to-severe plaque psoriasis. This nov...01 Dec, 2025, 11.28 AM IST
- Sun Pharma Advanced Research shares tank 20% after psoriasis drug fails Phase 2 trialsSun Pharma Advanced Research Company (SPARC) psoriasis drug, Vibozilimod (SCD-044), failed to meet primary endpoints in Phase 2 trials for ...04 Jun, 2025, 12.14 PM IST
- Eli Lilly forays into dermatological space with launch of psoriasis drugEli Lilly has launched a new drug to treat moderate-to-severe plaque psoriasis in India. The drug, Copellor, is designed to specifically ta...14 Mar, 2023, 12.18 PM IST
- Sun Pharma arm launches plaque psoriasis treatment drug in JapanIn a regulatory filing, Sun Pharmaceutical Industries said its "wholly-owned Japanese subsidiary has launched Ilumya Subcutaneous Injection...23 Sep, 2020, 10.40 AM IST
- Does winter mean psoriasis for you? Avoid stress, choose fragrance-free productsOne of the most common skin conditions, psoriasis causes skin cells to build up, and form shiny scales and itchy, dry red patches.31 Oct, 2017, 12.44 PM IST
- Sun Pharma announces details of psoriasis drug trialsTildrakizumab is a monoclonal antibody designed to control the pathogenic cells responsible for the inflammatory process of psoriasis with ...01 Oct, 2016, 07.38 PM IST
- Novartis Healthcare launches psoriasis treatment drug in IndiaNovartis Healthcare has launched secukinumab, used for the treatment of plaque psoriasis in adult patients, in India. The company has launc...17 Mar, 2016, 06.49 PM IST
- Biocon gets DCGI approval to market anti-psoriasis drug, Itolizumab"The company has received market authorisation from the DCGI for its novel biologic Itolizumab, for treatment of chronic plaque psoriasis,"...08 Jan, 2013, 02.27 PM IST
- Looking for global partner for psoriasis drug: Kiran Mazumdar Shaw, BioconThe plan is that the India drug will launched as an intravenous infusion and it has been indicated for psoriasis, says Kiran Mazumdar Shaw.08 Jan, 2013, 12.39 PM IST
Load More
